Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Lyra Therapeutics, Inc. Common Stock · LYRA

LYRAOTCCommon stockCurrentCIK 1327273Updated Oct 6, 2026

Company: Lyra Therapeutics, Inc. →

Name history
480 Biomedical, Inc. · through Nov 28, 2016Arsenal Vascular, Inc. · through Nov 8, 2011Arsenal Medical, Inc. · through Aug 12, 2010WMR Biomedical Inc · through Feb 27, 2009

LYRA price & chart

Provider market data

Loading TradingView…

OTC:LYRA on TradingView ↗

TradingView · Data may be delayed

About the company

We are a clinical-stage biotechnology company focused on the development and commercialization of innovative, anti-inflammatory therapies for the localized treatment of patients with chronic rhinosinusitis, or CRS. CRS is an inflammatory disease of the paranasal sinuses which leads to debilitating symptoms and significant morbidities and affects approximately 14 million people in the United States. Our primary product candidate, LYR-210, is a bioabsorbable nasal insert designed to be administered in a simple, in-office procedure and intended to deliver six months of continuous anti-inflammatory drug therapy to the sinonasal passages for the treatment of CRS with a single administration. The drug embedded within LYR-210 is mometasone furoate, or MF, which is the active ingredient in various U.S. Food and Drug Administration, or FDA, approved drugs and has a well-established efficacy and safety profile.

S-1 · 2025-07-22 · 0001193125-25-162669

Company description from the cited filing.

In the news

No coverage from other publishers is available.

SEC disclosures

Recent filings

  1. 4 filing

    4 · 2026-05-15 · 0001193125-26-227500

  2. 15-12G filing

    15-12G · 2026-04-30 · 0001193125-26-194908

  3. 25 filing

    25 · 2026-04-20 · 0001193125-26-164179

  4. Termination of a Material Definitive Agreement

    Items 1.02

    8-K · 2026-04-17 · 0001193125-26-160421

  5. Termination of a Material Definitive Agreement

    Items 1.02

    8-K · 2026-04-10 · 0001193125-26-150441

Show 5 more recent filings
  1. 10-K filing

    10-K · 2026-03-31 · 0001327273-26-000003

  2. EFFECT filing

    EFFECT · 2026-03-26 · 9999999995-26-000939

  3. EFFECT filing

    EFFECT · 2026-03-26 · 9999999995-26-000934

  4. EFFECT filing

    EFFECT · 2026-03-26 · 9999999995-26-000936

  5. S-8 POS filing

    S-8 POS · 2026-03-26 · 0001193125-26-124494

Financials

FY 2025 · USD
Revenue398,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

Net income-28,919,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

Operating income-31,022,000USD · FY 2025
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

Diluted EPS-18.62USD per share · FY 2025
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ3 2025Q3 2024Q3 2023Q2 2025Q2 2024Q2 2023Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
ASSETS
AssetsUSD43,709,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

78,756,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

120,575,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

52,573,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

94,582,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

125,675,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

56,316,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

141,527,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

36,108,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

66,346,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

142,600,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

109,968,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Property, Plant and Equipment, NetUSD1,122,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

1,613,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

726,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

1,159,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

1,665,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

560,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

1,276,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

3,783,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

1,051,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

1,404,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

2,043,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

2,243,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD22,055,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

23,800,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

24,850,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

29,784,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

31,905,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

54,361,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

31,735,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

15,799,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

15,893,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

40,577,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

22,353,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

32,550,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Assets, CurrentUSD23,019,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

54,444,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

104,920,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

31,063,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

69,435,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

118,253,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

33,905,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

89,443,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

16,272,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

43,025,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

104,821,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

100,829,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Prepaid Expense and Other Assets, CurrentUSD964,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

2,818,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

2,370,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

1,279,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

1,937,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

1,800,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

2,170,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

2,325,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

379,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

2,448,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

2,068,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

2,935,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Operating Lease, Right-of-Use AssetUSD17,575,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

20,707,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

6,074,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

18,358,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

21,490,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

1,420,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

19,142,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

45,626,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

16,792,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

19,924,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

33,233,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

2,223,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Other Assets, NoncurrentUSD——7,463,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

——4,353,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

—683,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

—0
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

1,111,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

3,281,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD48,037,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

58,137,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

36,336,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

50,951,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

63,605,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

27,098,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

52,444,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

64,023,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

46,825,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

54,752,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

53,180,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

29,214,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD2,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

65,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

50,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

2,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

65,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

50,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

66,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

61,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

2,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

65,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

57,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

32,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Retained Earnings (Accumulated Deficit)USD-426,758,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

-393,811,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

-296,199,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

-420,774,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

-381,938,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

-280,548,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

-413,337,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

-333,807,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

-433,709,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

-404,790,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

-311,355,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

-248,675,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD—20,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

-7,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

—-4,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

-27,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

—25,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

—0
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

33,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

10,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Stockholders' Equity Attributable to ParentUSD-4,328,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

20,619,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2024-09-30

84,239,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2023-09-30

1,622,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

30,973,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2024-06-30

98,577,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2023-06-30

3,872,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

77,504,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2024-03-31

-10,717,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

11,594,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

89,420,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

80,754,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Additional Paid in Capital, Common StockUSD422,428,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

414,345,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

380,395,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

422,394,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

412,854,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

379,102,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

417,143,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

411,225,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

422,990,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

416,319,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

400,685,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

329,387,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Liabilities and EquityUSD43,709,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

78,756,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

120,575,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

52,573,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

94,582,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

125,675,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

56,316,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

141,527,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

36,108,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

66,346,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

142,600,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

109,968,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Current liabilities:
Liabilities, CurrentUSD9,480,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

14,954,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

19,235,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

11,163,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

19,276,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

14,111,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

11,470,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

18,724,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

9,522,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

12,631,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

19,597,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

14,470,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Operating Lease, Liability, CurrentUSD4,684,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

4,003,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

1,403,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

4,552,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

4,269,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

1,688,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

4,243,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

4,504,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

4,818,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

4,121,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

5,434,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

1,549,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Accounts Payable, CurrentUSD627,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

2,292,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

5,054,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

680,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

4,971,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

4,188,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

725,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

2,844,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

663,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

1,179,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

3,131,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

2,616,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Operating Lease, Liability, NoncurrentUSD26,695,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

31,321,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

4,887,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

27,926,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

32,479,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

—29,113,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

33,356,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

25,441,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

30,259,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

21,447,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

667,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Additional Financial Items
Deferred Revenue, CurrentUSD7,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

607,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

1,726,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

32,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

814,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

1,497,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

216,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

1,319,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

—398,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

1,658,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

1,275,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Deferred Revenue, NoncurrentUSD11,862,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

11,862,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

12,214,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

11,862,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

11,850,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

12,987,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

11,861,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

11,943,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

11,862,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

11,862,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

12,136,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

14,077,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Short-term InvestmentsUSD—27,826,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

77,700,000
Source

10-Q · 2023-11-07 · 0000950170-23-060298

As of 2023-09-30

—35,593,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

61,789,000
Source

10-Q · 2023-08-08 · 0000950170-23-039830

As of 2023-06-30

—71,319,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

0
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

0
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

80,400,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

65,344,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD——————-8,547,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-22,452,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-28,919,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,435,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,680,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,278,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Share-based Payment Arrangement, Noncash ExpenseUSD——————825,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

2,162,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

2,335,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

6,716,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

5,887,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

5,447,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts PayableUSD——————-454,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-560,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-516,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-1,887,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

450,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-2,411,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD——————-8,842,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-22,455,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-28,859,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-70,011,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-63,304,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-43,385,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Cash flows from investing activities:
Net Cash Provided by (Used in) Investing ActivitiesUSD———————7,857,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-98,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

80,305,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-12,584,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-65,006,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Payments to Acquire Property, Plant, and EquipmentUSD———————2,149,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

116,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

2,338,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

1,047,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

164,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD———————8,644,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

4,273,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

8,531,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

65,691,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

96,257,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD——————-8,842,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-5,954,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-24,684,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

18,825,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-10,197,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-12,134,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD——24,048,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

As of 2025-09-30

25,792,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

As of 2024-09-30

31,777,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

As of 2025-06-30

33,897,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

As of 2024-06-30

33,728,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

As of 2025-03-31

17,791,000
Source

10-Q · 2024-04-30 · 0000950170-24-050535

As of 2024-03-31

17,886,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

As of 2025-12-31

42,570,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

As of 2024-12-31

23,745,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

As of 2023-12-31

33,942,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

As of 2022-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD——34,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

1,491,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

914,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

1,124,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

825,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

2,162,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

2,335,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

6,716,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

5,887,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

5,447,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

DepreciationUSD——100,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

—200,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

200,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

128,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

136,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

459,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

471,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

278,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,067,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD————————8,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

———
General and Administrative ExpenseUSD——2,236,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

3,931,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

3,501,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

5,139,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

3,263,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

5,818,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

11,540,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

18,501,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

19,057,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

17,556,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——3,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

7,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

2,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

12,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

4,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

14,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

11,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

39,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

59,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

13,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——256,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

576,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

410,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

855,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

298,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

1,086,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

1,133,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

2,952,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

4,499,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,041,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-5,984,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-11,873,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-7,437,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-48,131,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-8,547,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-22,452,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-28,919,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,435,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,680,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,278,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD————————-28,919,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,435,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,680,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,278,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——256,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

576,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

1,391,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

855,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

298,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

1,086,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

2,114,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

2,952,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

4,499,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,041,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Operating ExpensesUSD——6,262,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

12,637,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

9,009,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

49,572,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

9,024,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

24,056,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

31,420,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

97,882,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

68,678,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

57,669,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD————————5,100,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

6,400,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

2,000,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,100,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Payments to Acquire InvestmentsUSD———————20,525,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

—47,949,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

122,423,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

64,842,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD———————30,531,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

—130,592,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

——
Proceeds from Stock Options ExercisedUSD———————3,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

—3,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

103,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

8,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemQ4 2025Q4 2024Q3 2025Q3 2024Q2 2025Q2 2024Q1 2025Q1 2024FY 2025FY 2024FY 2023FY 2022
Total RevenueUSD——25,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

195,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

183,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

598,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

183,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

532,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

398,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

1,534,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

1,558,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,363,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Operating Income (Loss)USD——-6,237,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-12,442,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-8,826,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-48,974,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-8,841,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-23,524,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-31,022,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-96,348,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-67,120,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-56,306,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD——-5,981,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-11,866,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-7,435,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-48,119,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-8,543,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-22,438,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-28,908,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,396,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,621,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,265,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Income Tax Expense (Benefit)USD——3,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

7,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

2,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

12,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

4,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

14,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

11,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

39,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

59,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

13,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Net Income (Loss) Attributable to ParentUSD——-5,984,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-11,873,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-7,437,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-48,131,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-8,547,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-22,452,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-28,919,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,435,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,680,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,278,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Earnings Per Share, BasicUSD per share——-3.38
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-9.07
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-5.51
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-36.76
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-0.13
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-0.35
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-18.62
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-1.43
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-1.26
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-1.83
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Earnings Per Share, DilutedUSD per share——-3.38
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

-9.07
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

-5.51
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

-36.76
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

-0.13
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

-0.35
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

-18.62
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-1.43
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-1.26
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-1.83
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Basicshares——1,767,814
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

1,309,134
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

1,348,630
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

1,309,193
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

65,757,860
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

64,011,360
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

1,553,473
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

65,113,859
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

49,804,283
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

30,235,689
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares——1,767,814
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

1,309,134
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

1,348,630
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

1,309,193
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

65,757,860
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

64,011,360
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

1,553,473
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

65,113,859
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

49,804,283
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

30,235,689
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Additional Financial Items
General and Administrative ExpenseUSD——2,236,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

3,931,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

3,501,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

5,139,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

3,263,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

5,818,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

11,540,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

18,501,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

19,057,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

17,556,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Investment Income, InterestUSD——256,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

576,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

410,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

855,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

298,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

1,086,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

1,133,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

2,952,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

4,499,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,041,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD————————-28,919,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

-93,435,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

-62,680,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

-55,278,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Nonoperating Income (Expense)USD——256,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

576,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

1,391,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

855,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

298,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

1,086,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

2,114,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

2,952,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

4,499,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,041,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Operating ExpensesUSD——6,262,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

12,637,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

9,009,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

49,572,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

9,024,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

24,056,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

31,420,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

97,882,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

68,678,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

57,669,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Operating Lease, ExpenseUSD————————5,100,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

6,400,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

2,000,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

1,100,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Other IncomeUSD——0
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

0
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

981,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

0
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

——981,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

———
Research and Development ExpenseUSD——4,047,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2025-07-01 to 2025-09-30

5,902,000
Source

10-Q · 2025-11-12 · 0001193125-25-277564

2024-07-01 to 2024-09-30

5,110,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2025-04-01 to 2025-06-30

13,264,000
Source

10-Q · 2025-08-12 · 0000950170-25-107367

2024-04-01 to 2024-06-30

4,876,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2025-01-01 to 2025-03-31

18,238,000
Source

10-Q · 2025-05-06 · 0000950170-25-064495

2024-01-01 to 2024-03-31

18,411,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

43,766,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

48,029,000
Source

10-K · 2024-03-22 · 0000950170-24-035047

2023-01-01 to 2023-12-31

38,797,000
Source

10-K · 2023-03-29 · 0000950170-23-010632

2022-01-01 to 2022-12-31

Restructuring and Related Cost, Incurred CostUSD———2,800,000
Source

10-Q · 2024-11-12 · 0000950170-24-125494

2024-07-01 to 2024-09-30

—6,500,000
Source

10-Q · 2024-08-14 · 0000950170-24-097042

2024-04-01 to 2024-06-30

——1,500,000
Source

10-K · 2026-03-31 · 0001327273-26-000003

2025-01-01 to 2025-12-31

10,900,000
Source

10-K · 2025-03-13 · 0000950170-25-038751

2024-01-01 to 2024-12-31

——

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-264864

POS AM · 2026-03-26 · 0001193125-26-124477

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-272981

POS AM · 2026-03-26 · 0001193125-26-124481

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-278163

POS AM · 2026-03-26 · 0001193125-26-124474

Terms from the governing filing for this registration; not a claim that the offering is open today.

Registration 333-288872

S-1 · 2025-07-22 · 0001193125-25-162669

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

lyra-ex99_1.htm · 8-K · 2025-11-12

EX-99.1 2 lyra-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lyra Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission - WATERTOWN, Mass., November 12, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-act…

8-K · 2025-11-12 · 0001193125-25-277515

Read attachment ↗
d71675dex991.htm · 8-K · 2025-09-04

EX-99.1 2 d71675dex991.htm EX-99.1 EX-99.1 Investor Presentation September 2025 Exhibit 99.1 Forward Looking Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. All statements contained in this presentation that do not relate to matter…

8-K · 2025-09-04 · 0001193125-25-195384

Read attachment ↗
lyra-ex99_1.htm · 8-K · 2025-08-12

EX-99.1 2 lyra-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 for treatment of chronic rhinosinusitis (CRS) - - Financing announced in June 2025 extends cash runway into 3Q 2026 - WATERTOWN, Mass., Aug…

8-K · 2025-08-12 · 0000950170-25-107339

Read attachment ↗
lyra-ex99_2.htm · 8-K · 2025-08-12

EX-99.2 3 lyra-ex99_2.htm EX-99.2 Investor Presentation August 2025 Forward Looking Statement This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. All statements contained in this presentation that do not relate to matters of historical fact shoul…

8-K · 2025-08-12 · 0000950170-25-107339

Read attachment ↗
d75821dex41.htm · 8-K · 2025-06-27

EX-4.1 2 d75821dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT LYRA THERAPEUTICS, INC. Warrant Shares: _______ Initial Exercise Date: June 27, 2025 Issue Date: June 27, 2025 ───────────────────────────────────────────────────────────────────── THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subje…

8-K · 2025-06-27 · 0001193125-25-150301

Read attachment ↗
d75821dex42.htm · 8-K · 2025-06-27

EX-4.2 3 d75821dex42.htm EX-4.2 EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO…

8-K · 2025-06-27 · 0001193125-25-150301

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.